Obesema 0.25 mg Injection
In stock
Description
Obesema 0.25 mg Injection is a prescription medication manufactured by Alkem Laboratories containing the active ingredient Semaglutide. It is a GLP-1 receptor agonist primarily used for chronic weight management and type 2 diabetes management. The 0.25 mg dose is typically the initial initiation or titration dose used to help the body adjust to the medication
Specifications
| Active Ingredient | Semaglutide 1mg/1.5ml (0.68mg/ml) |
|---|---|
| Product Type | Pre-filled Pen / Injection Kit |
| Product Type | Pre-filled Pen / Injection Kit |
| Strength | 0.25 mg |
